These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14642329)

  • 1. 3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors.
    Chakraborti AK; Gopalakrishnan B; Sobhia ME; Malde A
    Eur J Med Chem; 2003; 38(11-12):975-82. PubMed ID: 14642329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.
    Chakraborti AK; Gopalakrishnan B; Sobhia ME; Malde A
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2473-9. PubMed ID: 12852946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV.
    Ducrot P; Andrianjara CR; Wrigglesworth R
    J Comput Aided Mol Des; 2001 Sep; 15(9):767-85. PubMed ID: 11776290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors.
    Chakraborti AK; Gopalakrishnan B; Sobhia ME; Malde A
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1403-8. PubMed ID: 12668000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists.
    Aher YD; Agrawal A; Bharatam PV; Garg P
    J Mol Model; 2007 Apr; 13(4):519-29. PubMed ID: 17345108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-alpha]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors.
    Castro A; Abasolo MI; Gil C; Segarra V; Martinez A
    Eur J Med Chem; 2001 Apr; 36(4):333-8. PubMed ID: 11461758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary substituted PDE4 inhibitors I: the synthesis and in vitro evaluation of a novel series of oxindoles.
    Hulme C; Poli GB; Huang FC; Souness JE; Djuric SW
    Bioorg Med Chem Lett; 1998 Jan; 8(2):175-8. PubMed ID: 9871649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel 5-hydroxy-1H-indole-3-carboxylates with anti-HBV activities based on 3D QSAR studies.
    Chai HF; Liang XX; Li L; Zhao CS; Gong P; Liang ZJ; Zhu WL; Jiang HL; Luo C
    J Mol Model; 2011 Aug; 17(8):1831-40. PubMed ID: 21053034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoMFA and CoMSIA studies on 5-hydroxyindole-3-carboxylate derivatives as 5-lipoxygenase inhibitors: generation of homology model and docking studies.
    Aparoy P; Suresh GK; Kumar Reddy K; Reddanna P
    Bioorg Med Chem Lett; 2011 Jan; 21(1):456-62. PubMed ID: 21084193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and 3D-QSAR study on 4-(1H-indazol-4-yl) phenylamino and aminopyrazolopyridine urea derivatives as kinase insert domain receptor (KDR) inhibitors.
    Wu X; Wu S; Chen WH
    J Mol Model; 2012 Mar; 18(3):1207-18. PubMed ID: 21695506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR studies on malonyl coenzyme A decarboxylase inhibitors.
    Patel MR; Talele TT
    Bioorg Med Chem; 2007 Jul; 15(13):4470-81. PubMed ID: 17482825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
    Adane L; Bharatam PV
    J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaternary substituted PDE IV inhibitors II: the synthesis and in vitro evaluation of a novel series of gamma-lactams.
    Hulme C; Moriarty K; Huang FC; Mason J; McGarry D; Labaudiniere R; Souness J; Djuric S
    Bioorg Med Chem Lett; 1998 Feb; 8(4):399-404. PubMed ID: 9871693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors.
    Yu S; Wang P; Li Y; Liu Y; Zhao G
    SAR QSAR Environ Res; 2013 Oct; 24(10):819-39. PubMed ID: 23988186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.
    Yoo J; Thai KM; Kim DK; Lee JY; Park HJ
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4271-4. PubMed ID: 17553682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-based QSAR study for a series of 3,3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors.
    Wang JH; Hou QQ; Tang K; Cheng XL; Dong LH; Liu YJ; Liu CB
    SAR QSAR Environ Res; 2011 Oct; 22(7-8):775-99. PubMed ID: 22004567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.